期刊文献+

腺病毒载体介导的TPO基因疗法对放射损伤小鼠造血功能重建的影响 被引量:1

Thrombopoietin gene therapy mediated by recombinant adenovirus vector on hemopoietic reconstitution of mice injured by 5 Gy γ irradiation
暂未订购
导出
摘要 目的研究腺病毒载体介导的TPO基因疗法对放射损伤小鼠造血功能重建的影响.方法将构建的TPO腺病毒经(AdCMVTPO)腹腔注射至5Gy放射损伤小鼠体内,并与注射空载体(AdCMVNull)相对照,检测外周血WBC、Hb及PLT的动态变化.结果空载体注射组于照射后产生严重的全血细胞下降:PLT于照后6~12d降至200×109/L以下,WBC于照后6~15d降至1.0×109/L以下,Hb于照后12~15d降至6.0g/L以下.AdCMVTPO治疗组PLT降低的程度减轻,其最低值高于200×109/L(P<0.05,与对照组最低值比较),且提早约2周恢复接近正常.同时也有一定程度的加速WBC和Hb恢复的作用.结论腺病毒载体介导的TPO基因疗法可显著促进放射损伤小鼠PLT的恢复,对Hb、WBC的恢复也具有一定的促进作用. Objective To study the thrombopoietin gene therapy mediated by recombinant adenovirus vector on hemopoietic reconstitution of mice injured by irradiation. Methods Replication-deflcient mouse thrombopoietin (TPO) cDNA recombinant adenoviruses (AdCMVTPO) was injected through intraperitoneal in the mice injured by 5.0Gy γirradiation, taken AdCMVNull as control. WBC, Hb and PLT were examined during the course. Results In animals receiving the AdCMVNull, the radiation induced a profound pancytopenia with the nadir of WBC bellow 1.0 × 10^9/L from 6d to 15d, Hb bellow 6.0g/L from 12d to 15d, and PLT bellow 200 × 10^9/L from 6d to 12d. When AdCMVTPO was administered immediately after irradiation, the platelet levels were sustained, with a nadir above 200 × 10^9/L at 6d (P〈0.05 compared to control at nadir). Further, the recovery to normal levels was accelerated by approximately two weeks. Interestingly, there was a trend towards accelerated recovery of the WBC, as well as the Hb. Conclusion The TPO gene therapy mediated by adenovirus vector could mainly accelerate the recovery of PLT and had some extent effect on the recovery of WBC and Hb.
出处 《重庆医学》 CAS CSCD 2005年第9期1286-1288,共3页 Chongqing medicine
基金 重庆市应用基础研究基金资助课题(2002)
关键词 腺病毒栽体 促血小板生成素 基因治疗 造血功能重建 adenovirus vector thrombopoietin gene therapy hemopoietic reconstitution
  • 相关文献

参考文献10

  • 1刘林,罗成基,粟永平.复制缺陷型人TPO重组腺病毒的构建与鉴定[J].第三军医大学学报,1999,21(5):314-317. 被引量:3
  • 2Reichardt P, Tilgner J, Hohenberger P, et al. Dose-intensive chemotherapy with ifosfamide, epirubicin, and filgrastim for adult patients with metastatic or locally advanced soft tissue sarcoma: a phase II study[J].J Clin Oncol,1998,16(4):1438.
  • 3Crawford J, George M. The role of hematopoietic growth factors in support of ifosfamide/carboplatin/etoposide chemotherapy[J].Semin Oncol,1995,22(3 Suppl 7):18.
  • 4Yan XQ, Lacey D, Fletcher F, et al. Chronic exposure to retroviral vector encoded MGDF(mpl-ligand) induces lineage-specific growth and differentiaton of megakaryocytes in mice[J].Blood,1995,96:4025.
  • 5Konishi H, Ochiya T, Sakamoto H, et al. Effective prevention of thrombocytopenia using adenovirus-mediated transfer of HST-11FGF-4 gene: in vivo and in vitro studies[J]. Leukemia,1997,11(Suppl 3):530.
  • 6Mashhour B, Couton D, Perricaudet M. In vivo adenovirus-mediated gene transfer into ocular tissues[J].Gene Ther,1994,1(2):122.
  • 7Eaton DL, de Sauvage FJ. Thrombopoietin: the primary regulator of megakaryocytopoiesis and thrombopoiesis[J].Exp Hematol,1997,25(1):1.
  • 8Yamada M, Komatsu N, Kirito K, et al. Thrombopoietin supports in vitro erythroid differentiation via its specific receptor c-Mpl in a human leukemia cell line[J].Cell Growth Differ,1998,9(6):487.
  • 9Tanimukai S, Kimura T, Sakabe H, et al. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro[J].Exp Hematol,1997,25(10):1025.
  • 10Wagemaker G, Neelis KJ, Hartong SC, et al. The efficacy of recombinant thrombopoietin in murine and nonhuman primate models for radiation-induced myelosuppression and stem cell transplantation[J].Stem Cells,1998,16(6):375..

共引文献2

同被引文献4

  • 1Cwirla SE,Balasubramanian P,Duffin DJ,et al.Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine[J].Science,1997,276(5319):1696
  • 2Illum L,Davis SS.Targeting of colloidal particles to the bone marrow[J].Life Sci,1987,40(16):1553
  • 3Moghimi SM,Illum L,Davis SS.Physiopathological and physicochemical considerations in targeting of colloid samnd drug carriers to the bone marrow[J].Cri Rev Thera Drug Carrier Sys,1990,7(3):187
  • 4崔一民,鲁云兰,魏树礼.利福平白蛋白微球肺组织靶向性动物实验研究[J].中国药学杂志,1999,34(9):603-604. 被引量:1

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部